In this cohort study, researchers evaluated associations between ultra-processed foods and dietary factors linked to colorectal cancer.

A qualitative study explored how the relationship between oncology and palliative care teams influences end-of-life care for patients with cancer.

The expansion marks the first therapy approved for patients with BCG-unresponsive non-muscle-invasive bladder cancer presenting with papillary-only disease.

Kiran K. Chauhan, MD, of the Mayo Clinic in Rochester, Minnesota, and colleagues reported use of MBRT for patients with superficial cutaneous and soft tissue malignancies from a single institution. A ...

Women who had genetic testing for inherited cancer risk years ago may want to ask about testing again, experts say. A person’s genes don’t change. But testing has come a long way, and many early tests ...

To address underrepresentation of people living with HIV (PWH) in ICI and targeted therapy trials, researchers investigated the use of nivolumab plus cabozantinib in previously treated PWH with ...

A randomized controlled trial compared thulium laser endoscopic en bloc resection (TmLRBT) with bipolar transurethral en bloc resection (bERBT) for primary non-muscle-invasive bladder cancer sized ...

Raw milk can make children and pregnant people seriously ill, and the nation’s pediatricians want families to know the risks. The American Academy of Pediatrics (AAP) has updated its policy statement ...

In this study, researchers aimed to clarify the relationship between BMI and lung cancer risk, as well as to gain mechanistic insights using clinical and preclinical modeling.

In this study, researchers evaluated a clinic visit alone compared with a clinic visit plus a chatbot-based intervention in adolescents and young adults with a hereditary cancer predisposition ...

Dr Don Dizon discusses how social media can break down barriers between clinicians and patients and why oncologists should ...

Adjuvant atezolizumab combined with mFOLFOX6 halved the risk of disease recurrence or death in patients with resected stage III mismatch repair–deficient colon cancer in the phase 3 ATOMIC trial.